Dr. Christopher Stokoe, MD
What this data tells you about Dr. Stokoe
Dr. Christopher Stokoe is a medical oncology in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Stokoe performed 56,944 Medicare services across 3,957 unique beneficiaries.
Between the years covered by Open Payments, Dr. Stokoe received a total of $77,266 from 45 pharmaceutical and/or device companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stokoe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 19,000 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 11,875 | $2 | $20 |
| Contrast dye for imaging (iodine-based) | 6,840 | $0 | $3 |
| Pembrolizumab injection (Keytruda) | 4,400 | $43 | $137 |
| Paclitaxel chemotherapy injection | 2,774 | $0 | $8 |
| Denosumab injection (Prolia/Xgeva) | 1,740 | $18 | $66 |
| Immune globulin infusion (Octagam) | 1,330 | $34 | $234 |
| Dexamethasone injection (steroid) | 1,044 | $0 | $1 |
| Blood draw (venipuncture) | 1,040 | $8 | $20 |
| Complete blood count (CBC) with differential | 949 | $8 | $36 |
| Comprehensive metabolic blood panel | 941 | $10 | $64 |
| Injection, granisetron hydrochloride, 100 mcg | 650 | $0 | $24 |
| Office visit, established patient (30-39 min) | 497 | $90 | $368 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 383 | $20 | $128 |
| Anti-nausea injection (Aloxi/palonosetron) | 350 | $1 | $114 |
| Injection of additional new drug or substance into vein | 301 | $12 | $108 |
| Office visit, established patient (20-29 min) | 227 | $55 | $250 |
| Administration of chemotherapy into vein, 1 hour or less | 184 | $98 | $707 |
| Ferritin level test (iron stores) | 169 | $13 | $60 |
| Iron level test | 166 | $6 | $27 |
| Iron binding capacity test | 166 | $9 | $35 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 149 | $89 | $657 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 143 | $1,109 | $4,802 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 141 | $47 | $313 |
| Injection, carboplatin, 50 mg | 135 | $2 | $300 |
| Drug injection, under skin or into muscle | 98 | $10 | $96 |
| Ct scan of chest with contrast | 76 | $42 | $821 |
| Lactate dehydrogenase (enzyme) level | 74 | $6 | $31 |
| Injection, diphenhydramine hcl, up to 50 mg | 69 | $1 | $7 |
| Injection, zoledronic acid, 1 mg | 65 | $7 | $431 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 64 | $22 | $157 |
| CT scan of abdomen and pelvis with contrast | 63 | $165 | $1,067 |
| Carcinoembryonic antigen (cea) protein level | 63 | $19 | $99 |
| Microscopic examination for white blood cells with manual cell count | 60 | $4 | $22 |
| Complete blood count (CBC), automated | 60 | $6 | $34 |
| Administration of additional new drug or substance into vein, 1 hour or less | 59 | $49 | $344 |
| Unclassified drugs | 59 | $1 | $8 |
| Infusion, normal saline solution , 1000 cc | 55 | $2 | $19 |
| Administration of chemotherapy into vein, each additional hour | 53 | $21 | $161 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 52 | $54 | $211 |
| Office visit, established patient, complex (40-54 min) | 49 | $123 | $496 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 43 | $16 | $100 |
| New patient office visit (45-59 min) | 37 | $124 | $565 |
| Infusion into a vein for hydration, each additional hour | 31 | $10 | $75 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 31 | $26 | $145 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 28 | $15 | $94 |
| Reticulated (young) platelet measurement | 24 | $35 | $143 |
| Drawing of blood for a medical problem | 22 | $70 | $264 |
| Infusion into a vein for hydration, 31-60 minutes | 20 | $23 | $256 |
| CT scan of chest, without contrast | 19 | $29 | $686 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 19 | $340 | $1,722 |
| Red blood count automated, with additional calculations | 16 | $5 | $26 |
| Ct scan of abdomen and pelvis without contrast | 15 | $65 | $560 |
| Blood creatinine level | 15 | $5 | $31 |
| Chest X-ray, 2 views | 11 | $8 | $61 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Stokoe is a mixed practice specialist, with above-average Medicare volume (top 19% in TX), and high industry engagement (speaking/promotional, top 18%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Stokoe experienced with iron sucrose injection (venofer)?
Does Dr. Stokoe receive payments from pharmaceutical companies?
How do Dr. Stokoe's costs compare to other medical oncologys in Plano?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology